CLIP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.863630E-01
Normal-vs-Stage2
7.164800E-01
Normal-vs-Stage3
1.574130E-02
Normal-vs-Stage4
5.616600E-01
Stage1-vs-Stage2
6.014800E-01
Stage1-vs-Stage3
2.112800E-01
Stage1-vs-Stage4
9.032000E-01
Stage2-vs-Stage3
2.508400E-01
Stage2-vs-Stage4
7.556200E-01
Stage3-vs-Stage4
4.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.080400E-01
Normal-vs-AfricanAmerican
7.111200E-01
Normal-vs-Asian
3.925400E-01
Caucasian-vs-AfricanAmerican
9.073600E-01
Caucasian-vs-Asian
5.295400E-01
AfricanAmerican-vs-Asian
5.369200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.312200E-01
Normal-vs-Female
7.883600E-01
Male-vs-Female
3.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.259600E-01
Normal-vs-Age(41-60Yrs)
9.230400E-01
Normal-vs-Age(61-80Yrs)
5.062600E-01
Normal-vs-Age(81-100Yrs)
7.407000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.263000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.974000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.539200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.518600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.307800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.278400E-01
Normal-vs-Daily Drinker
2.759800E-01
Normal-vs-Weekly Drinker
4.097000E-01
Normal-vs-Occasional Drinker
9.353800E-01
Normal-vs-Social Drinker
9.432600E-01
Non Drinker-vs-Daily Drinker
7.222000E-01
Non Drinker-vs-Weekly Drinker
9.590800E-01
Non Drinker-vs-Occasional Drinker
2.388000E-01
Non Drinker-vs-Social Drinker
3.131200E-01
Daily Drinker-vs-Weekly Drinker
7.695400E-01
Daily Drinker-vs-Occasional Drinker
8.575700E-02
Daily Drinker-vs-Social Drinker
1.533440E-01
Weekly Drinker-vs-Occasional Drinker
2.273400E-01
Weekly Drinker-vs-Social Drinker
3.238400E-01
Occasional Drinker-vs-Social Drinker
9.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.950200E-02
Normal-vs-Grade 2
4.344400E-02
Normal-vs-Grade 3
8.562200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.235420E-01
Grade 1-vs-Grade 3
4.265700E-02
Grade 1-vs-Grade 4
9.950200E-02
Grade 2-vs-Grade 3
3.403800E-01
Grade 2-vs-Grade 4
4.344400E-02
Grade 3-vs-Grade 4
8.562200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.516800E-01
Normal-vs-NonDiabetic
6.046600E-01
Diabetic-vs-NonDiabetic
8.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.553600E-01
Normal-vs-NoPancreatitis
5.976600E-01
Pancreatitis-vs-NoPancreatitis
9.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.252800E-01
Normal-vs-N1
6.885600E-01
N0-vs-N1
7.753600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.690000E-01
Normal-vs-TP53-NonMutant
1.728440E-02
TP53-Mutant-vs-TP53-NonMutant
7.962200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
